Laurent Gressot

2.9k total citations · 1 hit paper
7 papers, 1.8k citations indexed

About

Laurent Gressot is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Laurent Gressot has authored 7 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 1 paper in Surgery. Recurrent topics in Laurent Gressot's work include Lung Cancer Treatments and Mutations (5 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Research Studies (3 papers). Laurent Gressot is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Research Studies (3 papers). Laurent Gressot collaborates with scholars based in United States, Italy and Germany. Laurent Gressot's co-authors include Nathan Levitan, Mark Allen O’Rourke, Ronald L. Burkes, K. Mattson, Susan Coughlin, Janet Dancey, J. Bérille, Rodryg Ramlau, Richard J. Gralla and Frances A. Shepherd and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and American Journal of Otolaryngology.

In The Last Decade

Laurent Gressot

7 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

2000 1.7k citations Frances A. Shepherd, Janet Dancey et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laurent Gressot United States	6	1.6k	1.5k	310	167	90	7	1.8k
Shaharyar Canada	5	1.7k 1.1×	1.5k 1.0×	347 1.1×	210 1.3×	105 1.2×	6	2.0k
Symantha Melemed United States	12	1.2k 0.7×	990 0.7×	236 0.8×	190 1.1×	123 1.4×	16	1.4k
Klára Szondy Hungary	6	1.8k 1.1×	1.6k 1.0×	372 1.2×	204 1.2×	104 1.2×	11	2.1k
Ira A. Oliff United States	8	1.2k 0.8×	1.3k 0.8×	451 1.5×	226 1.4×	59 0.7×	12	1.7k
Saulius Cicėnas Lithuania	12	1.4k 0.9×	1.1k 0.7×	320 1.0×	230 1.4×	137 1.5×	45	1.7k
L. Fehrenbacher United States	14	1.4k 0.9×	1.4k 0.9×	355 1.1×	229 1.4×	52 0.6×	33	1.7k
Nadia Chouaki France	19	1.3k 0.9×	1.3k 0.8×	226 0.7×	210 1.3×	200 2.2×	48	1.7k
Jaromı́r Roubec Czechia	9	1.3k 0.8×	1.3k 0.8×	574 1.9×	170 1.0×	55 0.6×	23	1.7k
Thomas Goddemeier Germany	9	930 0.6×	966 0.6×	352 1.1×	179 1.1×	86 1.0×	18	1.3k
H. Spiridonidis United States	4	1.8k 1.1×	1.7k 1.1×	541 1.7×	288 1.7×	93 1.0×	8	2.1k

Countries citing papers authored by Laurent Gressot

Since Specialization

Citations

This map shows the geographic impact of Laurent Gressot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Gressot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Gressot more than expected).

Fields of papers citing papers by Laurent Gressot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Gressot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Gressot. The network helps show where Laurent Gressot may publish in the future.

Co-authorship network of co-authors of Laurent Gressot

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Gressot. A scholar is included among the top collaborators of Laurent Gressot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Gressot. Laurent Gressot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Shepherd, Frances A., Janet Dancey, Rodryg Ramlau, et al.. (2023). Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy. Journal of Clinical Oncology. 41(15). 2673–2681. 7 indexed citations

2.

Spigel, David R., Robert M. Jotte, Santiago Ponce Aix, et al.. (2020). Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non–Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial. Clinical Lung Cancer. 22(1). 6–15.e4. 11 indexed citations

3.

Spigel, David R., Robert M. Jotte, Santiago Ponce Aix, et al.. (2018). nab-paclitaxel + carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND.sqm study. Annals of Oncology. 29. viii749–viii750. 1 indexed citations

4.

Thomas, Michael, David R. Spigel, Robert M. Jotte, et al.. (2017). <em>nab</em>-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy. PubMed. Volume 8. 207–216. 5 indexed citations

5.

Robert, Nicholas J., Mansoor N. Saleh, Devchand Paul, et al.. (2011). Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial. Clinical Breast Cancer. 11(2). 82–92. 94 indexed citations

6.

Shepherd, Frances A., Janet Dancey, Rodryg Ramlau, et al.. (2000). Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy. Journal of Clinical Oncology. 18(10). 2095–2103. 1717 indexed citations breakdown →

7.

Teh, Bin S., Uma Monga, Jack Thornby, et al.. (2000). Concurrent chemotherapy and “concomitant boost” radiotherapy for unresectable head and neck cancer. American Journal of Otolaryngology. 21(5). 306–311. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact